Mostrar el registro sencillo del ítem
Análisis de dos esquemas de tratamiento con hierro oral e intravenoso en cirugía cardiaca : ensayo clínico en fase IV, randomizado, doble ciego y doble enmascarado
dc.contributor.advisor | Garrido Martín, Pilar | |
dc.contributor.advisor | Martínez Sanz, Rafael | |
dc.contributor.author | Rodríguez Fortúnez, Patricia María | es_ES |
dc.date.accessioned | 2014-05-13T11:18:27Z | |
dc.date.available | 2014-05-13T11:18:27Z | |
dc.date.issued | 2014 | |
dc.identifier.isbn | 978-84-15910-61-9 | |
dc.identifier.uri | http://riull.ull.es/xmlui/handle/915/100 | |
dc.description.abstract | Background: Anemia is a frequent complication after cardiopulmonary bypass surgery. Iron therapy has been variably employed by medical centres over the years. Objective: To test the clinical effectiveness of intravenous and oral iron supplementation in correcting anemia, and its impact on blood transfusion requirements, in patients undergoing cardiopulmonary bypass (CPB) surgery. Methods: A double-blind randomized placebo-controlled clinical trial with three parallel groups of patients. Group I (n=54): intravenous iron III-hydroxide sucrose complex, three doses of 100 mg /24 hours during pre- and postoperative hospitalization and 1 pill/24 h of oral placebo in the same period and during one month after discharge. Group II (n=53): oral ferrous fumarate iron 1 pill/24 hours pre- and postoperatively and during one month after discharge, and intravenous placebo while hospitalized. Group III (n=52): oral and intravenous placebo pre- and postoperatively, following the same protocol. Data were collected preoperatively, at theatre, at Intensive Care Unit admission, before hospital discharge and one month later. Results: 1) Baseline clinical and demographic characteristics and surgical procedures were similar in the three groups, 2) no inter-group differences were found in hemoglobin and hematocrit during the postoperative period, 3) the intravenous iron group showed higher serum ferritin levels at hospital discharge (1321±495 ng/mL; P<0.001) and one month later (610±387;P< 0.001) compared with the other groups, and 4) we did not observe statistical differences in blood transfusion requirements between the three groups. Conclusion: The use of intravenous or oral iron supplementation proved ineffective at correcting anemia after CPB and did not reduce blood transfusion requirements. | en_EN |
dc.format.mimetype | application/pdf | |
dc.language.iso | es | |
dc.publisher | Universidad de La Laguna, Servicio de Publicaciones | |
dc.rights | Licencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 internacional) | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es_ES | |
dc.title | Análisis de dos esquemas de tratamiento con hierro oral e intravenoso en cirugía cardiaca : ensayo clínico en fase IV, randomizado, doble ciego y doble enmascarado | es_ES |
dc.type | info:eu-repo/semantics/doctoralThesis | |
dc.subject.keyword | Cirugía del corazón | es |
dc.subject.keyword | Acción de los medicamentos | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
TD. Ciencias de la Salud
Tesis de Medicina, Farmacia, Enfermería, Fisioterapia, Psicología y Logopedia